Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in ...

Manchester, New Hampshire-based Sequel currently offers twiist for type 1 diabetes, launching earlier this year. It shared ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time ...

Investigational study marks Sequel’s first pivotal data in type 2 diabetes, the largest population on insulin therapy and one of the most under-served by automated insulin delivery ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...

A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...

ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

CHARLOTTESVILLE, Va. — A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by ...

A small study published in Diabetes Care, the journal of the American Diabetes Association, shows that personalized text messages with positive and negative feedback are more effective than texts that ...